Accueil › Syndromes myélodysplasiques › District de Columbia › Washington
Essais cliniques pour Syndromes myélodysplasiques à Washington, DC
20 études pour Syndromes myélodysplasiques recherchent des participants dans et autour de Washington (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Recrutement en coursPhase 2
- Walter Reed National Military Medical Center, Bethesda · à 7 mi
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Recrutement en coursPhase 1
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders
Recrutement en coursÉtude observationnelle
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
Recrutement en coursPhase 1/2
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Recrutement en coursPhase 2
- Walter Reed National Military Medical Center, Bethesda · à 7 mi
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
Recrutement en coursPhase 1/2
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
CHIP/CCUS Natural History Protocol
Recrutement en coursÉtude observationnelle
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
Natural History Study of GATA2 Deficiency and Related Disorders
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
Recrutement en coursPhase 2
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
Collection of Tissue Samples for Cancer Research
Recrutement en coursÉtude observationnelle
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Recrutement en coursPhase 1/2
- Children's National Medical Center, Washington D.C.
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
Recrutement en coursPhase 2
- The Center for Cancer and Blood Disorders (CCBD) - Bethesda, Bethesda · à 7 mi
Mosaic Trial for Stem Cell Transplant Recipients
Recrutement en cours
- Georgetown University School of Medicine, Washington D.C.
Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
Recrutement en coursPhase 2
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants
Recrutement en coursÉtude observationnelle
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Cancer Support Community Research & Training Institute, Washington D.C.
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Recrutement en coursPhase 1/2
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recrutement en coursÉtude observationnelle
- Massive Bio SYNERGY-AI site, Silver Spring · à 7 mi
- Massive Bio SYNERGY-AI site, Bethesda · à 7 mi
Essais pour Syndromes myélodysplasiques dans d'autres villes
- Houston, TX43 études
- Baldwin Park, CA26 études
- Seattle, WA21 études
- New York City, NY21 études
- Boston, MA19 études
- Tampa, FL19 études
- Miami, FL17 études
- Durham, NC14 études
- Columbus, OH14 études
- Chicago, IL13 études
- St. Louis, MO13 études
- Atlanta, GA13 études
Autres études à Washington
- Cancer (tous types)58 études
- Cancer du poumon non à petites cellules55 études
- Cancer du sein46 études
- Cancer métastatique43 études
- Cancer du poumon41 études
- Cancer de la prostate38 études
- Obésité33 études
- Cancer colorectal29 études
- Maladie cardiovasculaire28 études
- Cancer de la vessie26 études
- Leucémie aiguë myéloïde24 études
- Lymphome23 études
Source : ClinicalTrials.gov, données récupérées le 7 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.